Algene Holding SE, a subsidiary of DN Group AG (ISIN: DE000A3DW408), announced the successful first harvest of high-purity microalgae, achieving a yield of 4,500 liters. This milestone marks the start of series production after scaling up operations, with the microalgae intended for quality-critical applications in cosmetics, food, and pharmaceuticals. The production platform was developed in collaboration with the Technical University of Munich.
The company has already entered extensive discussions with well-known cosmetics firms for purchasing the microalgae. The initial delivery to a leading German cosmetics manufacturer is planned for the coming days, where the biomass will be used for laboratory tests and validation of active ingredients. This development positions Algene to capitalize on the rapidly growing market for microalgae, which the EU Commission projects to reach approximately €9 billion in Europe by 2030. Algae are considered a key component of the bioeconomy, and Algene is positioning itself as an industrial platform for controlled microalgae production, addressing markets such as nutrition, food, cosmetics, life sciences, and aquaculture.
Ole Nixdorff, CEO of DN Group, stated: "For Algene, the start of series production is an important milestone. The market for microalgae is growing rapidly and offers enormous potential. The high level of interest underlines the high quality of the Algene material and the good market acceptance. As a shareholder in Algene, DN Group participates in this future market."
This achievement has significant implications for the business and technology sectors. For leaders in cosmetics, food, and pharmaceuticals, the availability of high-purity microalgae from a reliable industrial platform could lead to new product innovations and sustainable sourcing options. The microalgae market's projected growth presents investment opportunities, and Algene's success may accelerate adoption of algae-based raw materials. DN Group, as an investor in impact companies, stands to benefit from this growth, reinforcing its strategy of supporting ESG-focused firms in future industries like AI, mobility, circular economy, food, health, and energy.
The broader impact on the industry includes potential shifts toward bio-based raw materials, reduced reliance on synthetic ingredients, and alignment with sustainability goals. As series production ramps up, Algene could become a key supplier, influencing supply chains and encouraging further research and development in microalgae applications.
